Knowledge Tree
Relations (1)
cross_type 2.32 — strongly supporting 4 facts
Johns Hopkins University is the institution that conducts clinical trials investigating the therapeutic use of psilocybin for major depressive disorder, as evidenced by the trial participation of Nora Osowski [1] and the specific procedural protocols established by the university [2]. The efficacy of this research is further supported by participant accounts detailing the psychological benefits and life-changing outcomes experienced during these trials [3], [4].
Facts (4)
Sources
History and Current Status of Psychedelics and Entactogens ... - NCBI ncbi.nlm.nih.gov 4 facts
accountNora Osowski participated in a clinical trial for psilocybin to treat major depressive disorder at Johns Hopkins University after failing to find relief with conventional antidepressants.
accountA participant in a Johns Hopkins psilocybin trial reported that the experience provided a profound feeling of relaxation, helped her reconnect with her core values, allowed her to reexamine her priorities, and enabled her to move beyond negative thought patterns.
procedureThe psilocybin clinical trial protocol at Johns Hopkins University for major depressive disorder includes preparatory visits with a facilitator, treatment sessions involving eyeshades and headphones with standardized music, and subsequent integrative sessions to process insights.
claimThe participant in the Johns Hopkins psilocybin trial credited the experience with providing the motivation to return to school and pursue a nursing degree.